Ana Mendes

Experience

• 

  Instituto Nacional de Saúde Dr Ricardo Jorge

  Jan 2004 - Jan 2010

  Carried a PhD project on the identification and characterisation of the pathways in which the WNK kinases participate. These proteins are involved not only in Metabolic diseases like Hypertension and Osteoporosis but also with Cystic Fibrosis and Cancer. Professional Training in Cell culture protocols and recombinant DNA technology of the Instituto de Emprego e Formação Profissional, with the final grade of Very Good. Final Research Project entitled: Search and characterization of rare mutations in genes associated with Hereditary Hemochromatosis, with the final grade of 90 (out of 100).

  • PhD Student

    Jan 2006 - Jan 2010

  • Professional training internship

    Jan 2005 - Jan 2006

  • Undergraduate student

    Jan 2004 - Jan 2005
• 

  Eurotrials

  Jan 2011 - Oct 2015

  Monitoring activities in:- Oncology (Advanced or metastatic Pancreatic Adenocarcinoma) – Phase III study- Neurology (Schizophrenia) – Phase III study (unblinded Independent Drug monitor)- Ophthalmology (high risk proliferative Diabetic Retinopathy) – Phase II/III study- Dislipidemia (heterozygous familial Hypercholesterolemia) – Phase III study- Cardiology (ST-elevation myocardial infarction) – Phase II study- Rheumatology (Rheumatoid Arthritis) – Phase IV studyFeasibility activities, including site identification, site contacts, feasibility assessments questionnaires and site selection visits Show less Monitoring activities in:- Neurology (Spasticity due to stroke or traumatic brain injury) – Phase III study- Neurology (Schizophrenia) – Phase III study (unblinded Independent Drug monitor)- Urology (Benign Prostatic Hyperplasia), Phase IV- Ophthalmology (Macular Edema secondary to Diabetes Mellitus), Phase IIIb- Ophthalmology (high risk proliferative Diabetic Retinopathy) – Phase II/III study- Dislipidemia (heterozygous familial Hypercholesterolemia) – Phase III study- Dislipidemia & Diabetes – Phase II study Feasibility activities, including site identification, site contacts, feasibility assessments questionnaires and site selection visits, in:- HIV, Phase IIIb- Spasticity due to due to stroke or traumatic brain injury, Phase III- Pediatric allergic rhinoconjunctivitis or chronic urticaria, Phase III- Opioid-induced Constipation in patients with non-malignant Chronic Pain, Phase III- ST-elevation myocardial infarction, Phase II- Advanced or metastatic Pancreatic Adenocarcinoma, Phase III study- Stage IV pancreatic adenocarcinoma, Phase III Show less Main Activities include but are not limited to:- Ongoing CRA support as Project In-house CRA- Preparation and collection of essential documents in accordance with the client SOPs and applicable local regulatory requirements- Site regulatory package compilation for Investigational Product shipment to the site- CRA Support in Qualification, Initiation, Monitoring and Close-out Visits, as well as, Audits and Inspections- Site management including assistance with Queries resolution and SAE expedited reporting by Investigator- On-Site visits with the CRA for: Verification of patients eligibility and compliance with Informed Consent procedures, Source Data Verification versus CRFs, Laboratory Kits Management, Investigational Product Accountability and Reconciliation of Investigator Site File- Translation and Validation of Translation of study documentation- Communication with the international project and site teams- Provide training remotely to site staff and new collaborators at the company- Liaison with other CRAs/Project Managers/Data Managers/Statisticians/ Medical Writers- ISF and TMF update and shipment directly to Sponsor after performing the final Quality Check- Quality assurance Show less

  • Clinical Research Associate II

    Oct 2014 - Oct 2015

  • Clinical Research Associate I

    Jan 2012 - Sept 2014

  • CRA in training

    Oct 2011 - Dec 2011

  • Clinical Trials Assistant (CTA or CMA)

    Jan 2011 - Sept 2011
• 

  IQVIA

  Oct 2015 - now

  Training to become a Clinical lead, including shadowing activities for the senior Clinical lead who was my mentor during this periodCo-monitoring visits in Portugal with junior CRAs as well as office mentoring activities for junior CRAs in other countriesIn addition, Monitoring activities in:- Neurology (Multiple Sclerosis) – Phase IV study- Neurology (Alzheimer's disease) – Phase III study- Oncology (Lung cancer) – Phase III study- Oncology (Lymphoma) – Phase IV study- Oncology (Breast cancer) - Phase III study Show less Monitoring activities in:- Neurology (Multiple Sclerosis) – Phase IV study- Neurology (Alzheimer's disease) – Phase III study- Oncology (Lung cancer) – Phase III study- Oncology (Lymphoma) – Phase IV study- Oncology (Melanoma) – Phase IV study- Gastroenterology (Ulcerative Colitis) – 3 Phase III studies (unblinded monitor)Site selection visits in:- Oncology (Head and Neck cancer) – Phase III study- Oncology (Ovarian cancer) – Phase III study- Neurology (Stroke) - Phase III study- Neurology (pediatric MS) - Phase III study - Cardiovascular (Pulmonary arterial hypertension) - Phase III study Show less

  • Clinical Lead

    Nov 2019 - now

  • Executive CRA

    Jan 2019 - Nov 2019

  • Feasibility specialist / Site ID specialist

    Aug 2017 - Nov 2019

  • Senior Clinical Research Associate

    Oct 2015 - Dec 2018